Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|August 13, 2025
Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in JapanKota Oshima, Yuna Hattori, Keiko Ihara, et al.
European Journal of Cardiovascular Nursing|September 11, 2023
Patient concern regarding bleeding side effects from oral anticoagulation therapy for atrial fibrillation: an analysis from the multicentre KiCS-AF registryIkuko Ueda, Shun Kohsaka, Nobuhiro Ikemura, et al.
Journal of Medical Internet Research|November 23, 2021
Clinical Effectiveness and Cost-effectiveness of Videoconference-Based Integrated Cognitive Behavioral Therapy for Chronic Pain: Randomized Controlled TrialKayoko Taguchi, Noriko Numata, Rieko Takanashi, et al.
BMC Neurology|December 30, 2022
Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysisTsubasa Takizawa, Seiya Ohtani, Narumi Watanabe, et al.
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Scientific Reports|April 1, 2017
Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencingHaruhiko Takeda, Yoshihide Ueda, Tadashi Inuzuka, et al.
Annals of Surgical Oncology|June 1, 2023
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgery|July 15, 2022
Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal Cancer in JapanSatoru Matsuda, Yuko Kitagawa, Ryo Takemura, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 2, 2022
A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinomaSatoru Matsuda, Yuko Kitagawa, Hirofumi Kawakubo, et al.
Annals of Surgery|December 20, 2022
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Pageof 12